Searched for
TETRAVALENT
India moves closer to dengue vaccine as final trials underwayAn Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. ...- 70% enrolment of participants for Phase III clinical trial of dengue vaccine completed: CentreIndia achieves a milestone in dengue prevention. The DengiAll vaccine trial sees 70% participant enrollment. ICMR leads the multi-center st...
- Phase-3 clinical trial enrolment for India's first dengue vaccine to be completed by October: ICMRIndia's DengiAll vaccine trial is nearing completion. ICMR scientists anticipate enrolling 10,500 participants by October across 20 Indian ...
- Takeda to launch dengue vaccine in India next yearTakeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...
- First-ever phase-three clinical trial for dengue vaccine initiated in IndiaThe Indian Council of Medical Research (ICMR) and Panacea Biotec have launched the first phase three clinical trial for an indigenous dengu...
- CDSCO panel gives nod for continuation of phase-II clinical trial of SII's dengue vaccineAn expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successf...
- Takeda to soon start trials in India for dengue vaccineTakeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...
- Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccineJapanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...
- Panacea Biotec completes Phase I/II study of DengiAlI vaccineAccording to the World Health Organization, dengue represents one of the 10 biggest global health threats and it is critical to have access...
- Zydus Cadila to launch seasonal flu vaccine in IndiaDisease prevention is key to public health in both developing and the developed world and vaccines have the potential to improve the qualit...
- Where are we faltering when it comes to countering deadly dengueThe mosquito-borne disease can be controlled only by the participation of the community as a whole, not just by an individual or a group.
- World's first dengue vaccine outAsian countries spend an estimated $6.5 billion annually in both direct and indirect medical costs due to dengue.
- Government may exempt Sanofi’s dengue vaccine from large-scale clinical trialsIf cleared, the step may eventually pave the way for Dengvaxia's availability via the wide government distribution system and private chann...
- World's first dengue vaccine gets nod after 20 years of researchThe injection can thwart all four types of the virus, which has appeared in Portugal, France, Florida and Japan recently, according to WHO.
- WHO delists Shantha bestsellerShantha Biotech’s bread-winner vaccine has fallen out of favour with the World Health Organisation.
- 5-in-1 booster shot for immunisationThe government is expected to upgrade the existing three-in-once vaccine for infants to a five-in-one by the end of the year under the nati...
- Pharma booming in tomorrow's worldFor a change, the bottomline and the bottom rung match up. India’s emerging pharma frat knows how to cash in low and cash out to grow-they ...
Load More
